Pharmacology Study of Aerosolized Liposomal
NCT00250120
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Conditions
Lung Diseases
Cancer
Interventions
DRUG:
L9NC: Liposomal 9-Nitro-20 (S)-Camptothecin
Sponsor
University of New Mexico